Trial no.:
|
PACTR201901631942297 |
Date of Approval:
|
24/01/2019 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Training caregivers to enhance early child neurodevelopment in the prevention of konzo disease from toxic cassava in the Democratic Republic of Congo |
Official scientific title |
Training caregivers to enhance early child neurodevelopment in the prevention of konzo disease from toxic cassava in the Democratic Republic of Congo |
Brief summary describing the background
and objectives of the trial
|
Konzo is an irreversible neurological disease of sudden onset with permanent partial paralysis in the legs. It is caused by chronic consumption of poorly processed cassava that has high levels of cyanide, and affects mostly women and children. We are the first group to document neurocognitive affects in konzo, and disease risk in very young children. Brain development is affected much more and at an earlier stage than previously known. The DR Congo government, with the support of WHO, is beginning to train mothers in konzo outbreak regions to use a cassava processing wetting method (WTM) that can make remove the cyanide from the cassava flour before eaten. We will embed WTM training within Early Childhood Development (ECD) caregiver training that will better motivate the use of the WTM to save the family from konzo. This ECD program also gives moms practical strategies for stimulating cognitive/physical development while using WTM to save children's brains from cyanide in the food.
The principal objective of the present partnership proposal is to adapt the caregiver training and child neurodevelopmental assessment capacity to a community-based intervention model for the prevention of konzo in the DR Congo
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Mental and Behavioural Disorders,Nervous System Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Education /Training |
Anticipated trial start date |
30/06/2018 |
Actual trial start date |
01/03/2019 |
Anticipated date of last follow up |
30/09/2019 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
400 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|